In order to receive high-level, strategic advice and input from industry, ELIXIR has establised an Industry Advisory Committee (IAC), made up of experts from users, including SMEs, suppliers and publishers. The ELIXIR Board appoints the IAC.
|Ian Barrett||AstraZeneca, UK|
|Iain Hrynaszkiewicz||Springer Nature, UK|
|Andreas Kremer||ITTM, Luxembourg|
|Natalia Jiménez Lozano||Atos, Spain|
|Filip Pattyn||Ontoforce, Belgium|
|Sara Paulina de Oliveira Monteiro||The Navigator Company, Portugal|
|Christian Paulitz||Bayer CropScience, Germany|
|Elizabeth Reynolds (Chair)||General Bioinformatics, UK|
|Sándor Szalma||Takeda Pharmaceuticals, USA|
|Philippe Sanseau||GlaxoSmithKline, UK|
|Abel Ureta-Vidal (Vice Chair)||Eagle Genomics, UK|
For 2018, the Chair of the IAC is Elizabeth Reynolds , with Abel Ureta-Vidal as Vice Chair.
The report from the first Industry Advisory Committee meeting - 26 February 2015 can be found here.
The report from the second Industry Advisory Committee meeting - 14 January 2016 can be found here.
The report from the third Industry Advisory Committee meeting - 25 January 2017 can be found here.
The report from the fouth Industry Advisory Committee meeting - 25 January 2018 can be found here.